Literature DB >> 16444862

ADMA: an emerging cardiovascular risk factor.

Rainer H Böger, John P Cooke, Patrick Vallance.   

Abstract

Mesh：

Substances：

Year:  2005        PMID： 16444862     DOI： 10.1177/1358836X0501000101

Source DB:  PubMed          Journal:  Vasc Med        ISSN： 1358-863X            Impact factor:   3.239


× No keyword cloud information.
  11 in total

1.  Crystal structure of the plant epigenetic protein arginine methyltransferase 10.

Authors:  Yuan Cheng; Monica Frazier; Falong Lu; Xiaofeng Cao; Matthew R Redinbo
Journal:  J Mol Biol       Date:  2011-10-01       Impact factor: 5.469

2.  Reference intervals for plasma L-arginine and the L-arginine:asymmetric dimethylarginine ratio in the Framingham Offspring Cohort.

Authors:  Nicole Lüneburg; Vanessa Xanthakis; Edzard Schwedhelm; Lisa M Sullivan; Renke Maas; Maike Anderssohn; Ulrich Riederer; Nicole L Glazer; Ramachandran S Vasan; Rainer H Böger
Journal:  J Nutr       Date:  2011-10-26       Impact factor: 4.798

Review 3.  AGXT2: a promiscuous aminotransferase.

Authors:  Roman N Rodionov; Natalia Jarzebska; Norbert Weiss; Steven R Lentz
Journal:  Trends Pharmacol Sci       Date:  2014-10-13       Impact factor: 14.819

4.  Human alanine-glyoxylate aminotransferase 2 lowers asymmetric dimethylarginine and protects from inhibition of nitric oxide production.

Authors:  Roman N Rodionov; Daryl J Murry; Sarah F Vaulman; Jeff W Stevens; Steven R Lentz
Journal:  J Biol Chem       Date:  2009-12-14       Impact factor: 5.157

Review 5.  How May Proton Pump Inhibitors Impair Cardiovascular Health?

Authors:  Roman A Sukhovershin; John P Cooke
Journal:  Am J Cardiovasc Drugs       Date:  2016-06       Impact factor: 3.571

6.  Dimethylarginine metabolism during acute and chronic rejection of rat renal allografts.

Authors:  Dariusz Zakrzewicz; Anna Zakrzewicz; Sigrid Wilker; Rolf-Hasso Boedeker; Winfried Padberg; Oliver Eickelberg; Veronika Grau
Journal:  Nephrol Dial Transplant       Date:  2010-07-19       Impact factor: 5.992

7.  Asymmetric and symmetric dimethylarginines and mortality in patients with hematological malignancies-A prospective study.

Authors:  Angelika Chachaj; Jerzy Wiśniewski; Justyna Rybka; Aleksandra Butrym; Monika Biedroń; Małgorzata Krzystek-Korpacka; Mariusz Grzegorz Fleszar; Maciej Karczewski; Tomasz Wróbel; Grzegorz Mazur; Andrzej Gamian; Andrzej Szuba
Journal:  PLoS One       Date:  2018-05-22       Impact factor: 3.240

Review 8.  Oxidative Stress and Cardiovascular Aging: Interaction Between NRF-2 and ADMA.

Authors:  Nandini Nair; Enrique Gongora
Journal:  Curr Cardiol Rev       Date:  2017

Review 9.  The Second Life of Methylarginines as Cardiovascular Targets.

Authors:  Natalia Jarzebska; Arduino A Mangoni; Jens Martens-Lobenhoffer; Stefanie M Bode-Böger; Roman N Rodionov
Journal:  Int J Mol Sci       Date:  2019-09-17       Impact factor: 5.923

10.  Specific Lowering of Asymmetric Dimethylarginine by Pharmacological Dimethylarginine Dimethylaminohydrolase Improves Endothelial Function, Reduces Blood Pressure and Ischemia-Reperfusion Injury.

Authors:  Young Lee; Purvi Mehrotra; David Basile; Mahbub Ullah; Arshnoor Singh; Nicholas Skill; Subhi Talal Younes; Jennifer Sasser; Anantha Shekhar; Jaipal Singh
Journal:  J Pharmacol Exp Ther       Date:  2020-11-19       Impact factor: 4.402
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.